Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Partial loss-of-function mutations in GINS4 lead to NK cell deficiency with neutropenia
Matilde I. Conte, … , Emily M. Mace, Jordan S. Orange
Matilde I. Conte, … , Emily M. Mace, Jordan S. Orange
Published November 8, 2022
Citation Information: JCI Insight. 2022;7(21):e154948. https://doi.org/10.1172/jci.insight.154948.
View: Text | PDF
Research Article Cell biology Immunology

Partial loss-of-function mutations in GINS4 lead to NK cell deficiency with neutropenia

  • Text
  • PDF
Abstract

Human NK cell deficiency (NKD) is a primary immunodeficiency in which the main clinically relevant immunological defect involves missing or dysfunctional NK cells. Here, we describe a familial NKD case in which 2 siblings had a substantive NKD and neutropenia in the absence of other immune system abnormalities. Exome sequencing identified compound heterozygous variants in Go-Ichi-Ni-San (GINS) complex subunit 4 (GINS4, also known as SLD5), an essential component of the human replicative helicase, which we demonstrate to have a damaging impact upon the expression and assembly of the GINS complex. Cells derived from affected individuals and a GINS4-knockdown cell line demonstrate delayed cell cycle progression, without signs of improper DNA synthesis or increased replication stress. By modeling partial GINS4 depletion in differentiating NK cells in vitro, we demonstrate the causal relationship between the genotype and the NK cell phenotype, as well as a cell-intrinsic defect in NK cell development. Thus, biallelic partial loss-of-function mutations in GINS4 define a potentially novel disease-causing gene underlying NKD with neutropenia. Together with the previously described mutations in other helicase genes causing NKD, and with the mild defects observed in other human cells, these variants underscore the importance of this pathway in NK cell biology.

Authors

Matilde I. Conte, M. Cecilia Poli, Angelo Taglialatela, Giuseppe Leuzzi, Ivan K. Chinn, Sandra A. Salinas, Emma Rey-Jurado, Nixa Olivares, Liz Veramendi-Espinoza, Alberto Ciccia, James R. Lupski, Juan Carlos Aldave Becerra, Emily M. Mace, Jordan S. Orange

×

Figure 4

Individual-derived BLCLs and GINS4-KD RPE hTERT cells have a mild delay in cell cycle progression.

Options: View larger image (or click on image) Download as PowerPoint
Individual-derived BLCLs and GINS4-KD RPE hTERT cells have a mild delay ...
(A) Cell cycle progression analysis in GINS4 family members and 2 HD-derived BLCL at early passages, shortly pulsed with BrdU and analyzed by FACS after 6 and 9 hours. One representative experiment of 3 independent replicates is shown. (B) Relative frequency of 2N BrdU+cells shortly pulsed with BrdU and analyzed by FACS after 9 hours in family members’ BLCL compared with pooled HD showing the mean ± SD of 3 independent experiments. P ≤ 0.05 1-sample 2-tailed t test and Wilcoxon test. (C) Representative plots of EdU BrdU double pulse of siblings, healthy parents, and HD-derived BLCL. (D) Relative frequency of EdU−BrdU+ cells compared with pooled HD values showing the mean ± SD of 4 independent experiments. P ≤ 0.05 1-sample 2-tailed t test and Wilcoxon test. (E) Representative GINS4 expression in GINS4 KD and control vector RPE hTERT cell line by Western blot. Actin (ACT) is used as a loading control. (F) Relative frequency of 2N BrdU+ cells in GINS4 KD compared with the control vector displaying the mean ± SD of 3 independent experiments. P ≤ 0.05 1-sample 2-tailed t test and Wilcoxon test.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts